Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...

The startups are the fourth and fifth drugmakers to file for initial public offerings since late December — the most notable ...

Author, public speaker, Olympic torch bearer, and “Cystic Fibrosis Warrior” Andrew Cary Lipman died at age 51 on Jan. 17.

While some analysts expect the 2025 IPO market to be relatively cool in the near-term, others anticipate more bids than in ...

Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction representing a critical and often overlooked complication.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

The looming awareness of my own mortality from cystic fibrosis fueled years of substance misuse. But after hitting bottom and seeking help through a health program, I have been sober since August 2024 ...

D Molecular Therapeutics reaches agreement with FDA for phase 3 trial design of DME candidate 4D-150, showing promising ...

Because cystic fibrosis affects multiple organ systems, including the lungs and digestive system, people with the condition often need care from a team of healthcare professionals. Cystic fibrosis ...

But there's a lot more information - how susceptible or prone you are to risk-factors such as hypertension, cancer, and even inherited disorders such as sickle cell anaemia or cystic fibrosis.

It is intended for individuals with chronic obstructive pulmonary disease (COPD), Cystic Fibrosis, Bronchiectasis, and Primary Ciliary Dyskinesia, who can independently generate a cough.

Vertex's dominance in the cystic fibrosis (CF) drug market, including recent FDA approval for Alyftrek, ensures strong revenue and market expansion. The company's pipeline diversification ...